344 related articles for article (PubMed ID: 30995464)
1. Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment.
Cook SG; Goodell DJ; Restrepo S; Arnold DB; Bayer KU
Cell Rep; 2019 Apr; 27(3):658-665.e4. PubMed ID: 30995464
[TBL] [Abstract][Full Text] [Related]
2. Stimulating β-adrenergic receptors promotes synaptic potentiation by switching CaMKII movement from LTD to LTP mode.
Larsen ME; Buonarati OR; Qian H; Hell JW; Bayer KU
J Biol Chem; 2023 Jun; 299(6):104706. PubMed ID: 37061000
[TBL] [Abstract][Full Text] [Related]
3. CaMKII T286 phosphorylation has distinct essential functions in three forms of long-term plasticity.
Cook SG; Rumian NL; Bayer KU
J Biol Chem; 2022 Sep; 298(9):102299. PubMed ID: 35872016
[TBL] [Abstract][Full Text] [Related]
4. Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression.
Gardoni F; Mauceri D; Malinverno M; Polli F; Costa C; Tozzi A; Siliquini S; Picconi B; Cattabeni F; Calabresi P; Di Luca M
J Neurosci; 2009 Jan; 29(3):669-77. PubMed ID: 19158293
[TBL] [Abstract][Full Text] [Related]
5. Differential stimulus-dependent synaptic recruitment of CaMKIIα by intracellular determinants of GluN2B.
She K; Rose JK; Craig AM
Mol Cell Neurosci; 2012 Nov; 51(3-4):68-78. PubMed ID: 22902837
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus.
Raymond CR; Ireland DR; Abraham WC
Brain Res; 2003 Apr; 968(2):263-72. PubMed ID: 12663096
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity.
Zeng Y; Zhao D; Xie CW
J Alzheimers Dis; 2010; 21(3):823-31. PubMed ID: 20634586
[TBL] [Abstract][Full Text] [Related]
8. CaMKII Metaplasticity Drives Aβ Oligomer-Mediated Synaptotoxicity.
Opazo P; Viana da Silva S; Carta M; Breillat C; Coultrap SJ; Grillo-Bosch D; Sainlos M; Coussen F; Bayer KU; Mulle C; Choquet D
Cell Rep; 2018 Jun; 23(11):3137-3145. PubMed ID: 29898386
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of synaptic depression induced by CaMKIIN, an endogenous inhibitor of CaMKII.
Gouet C; Aburto B; Vergara C; Sanhueza M
PLoS One; 2012; 7(11):e49293. PubMed ID: 23145145
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
11. Long-term potentiation in cultured hippocampal neurons.
Molnár E
Semin Cell Dev Biol; 2011 Jul; 22(5):506-13. PubMed ID: 21807105
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
Klyubin I; Ondrejcak T; Hayes J; Cullen WK; Mably AJ; Walsh DM; Rowan MJ
Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130147. PubMed ID: 24298149
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease.
Reese LC; Laezza F; Woltjer R; Taglialatela G
J Neurochem; 2011 Nov; 119(4):791-804. PubMed ID: 21883216
[TBL] [Abstract][Full Text] [Related]
14. Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.
Roselli F; Tirard M; Lu J; Hutzler P; Lamberti P; Livrea P; Morabito M; Almeida OF
J Neurosci; 2005 Nov; 25(48):11061-70. PubMed ID: 16319306
[TBL] [Abstract][Full Text] [Related]
15. cAMP-dependent protein kinase postsynaptic localization regulated by NMDA receptor activation through translocation of an A-kinase anchoring protein scaffold protein.
Smith KE; Gibson ES; Dell'Acqua ML
J Neurosci; 2006 Mar; 26(9):2391-402. PubMed ID: 16510716
[TBL] [Abstract][Full Text] [Related]
16. DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific.
Goodell DJ; Zaegel V; Coultrap SJ; Hell JW; Bayer KU
Cell Rep; 2017 Jun; 19(11):2231-2243. PubMed ID: 28614711
[TBL] [Abstract][Full Text] [Related]
17. Distinct trafficking and expression mechanisms underlie LTP and LTD of NMDA receptor-mediated synaptic responses.
Peng Y; Zhao J; Gu QH; Chen RQ; Xu Z; Yan JZ; Wang SH; Liu SY; Chen Z; Lu W
Hippocampus; 2010 May; 20(5):646-58. PubMed ID: 19489005
[TBL] [Abstract][Full Text] [Related]
18. The N-methyl-D-aspartate receptor antagonist CPP alters synapse and spine structure and impairs long-term potentiation and long-term depression induced morphological plasticity in dentate gyrus of the awake rat.
Medvedev NI; Popov VI; Rodriguez Arellano JJ; Dallérac G; Davies HA; Gabbott PL; Laroche S; Kraev IV; Doyère V; Stewart MG
Neuroscience; 2010 Feb; 165(4):1170-81. PubMed ID: 19961908
[TBL] [Abstract][Full Text] [Related]
19. Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B.
Bayer KU; LeBel E; McDonald GL; O'Leary H; Schulman H; De Koninck P
J Neurosci; 2006 Jan; 26(4):1164-74. PubMed ID: 16436603
[TBL] [Abstract][Full Text] [Related]
20. Local and Use-Dependent Effects of β-Amyloid Oligomers on NMDA Receptor Function Revealed by Optical Quantal Analysis.
Sinnen BL; Bowen AB; Gibson ES; Kennedy MJ
J Neurosci; 2016 Nov; 36(45):11532-11543. PubMed ID: 27911757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
